Complete response to pembrolizumab in a patient with recurrent and metastatic urothelial bladder carcinoma reflecting coexisting sarcomatoid subtype and glandular differentiation: a case report.
Yu MiyamaKent KanaoKousuke UranishiMasataka HirasakiMasanori YasudaPublished in: International cancer conference journal (2022)
The online version contains supplementary material available at 10.1007/s13691-022-00568-5.